These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 21456391)
1. Are we ready for neoadjuvant therapy in potentially resectable pancreatic cancer? Philip PA Oncology (Williston Park); 2011 Feb; 25(2):189-90, 192. PubMed ID: 21456391 [No Abstract] [Full Text] [Related]
2. Adjuvant and neoadjuvant therapy for pancreatic cancer. Vinciguerra V Oncology (Williston Park); 2011 Feb; 25(2):192-3. PubMed ID: 21456392 [No Abstract] [Full Text] [Related]
3. A neoadjuvant strategy for the management of nonmetastatic pancreatic cancer. Goff SL; Chabot JA Cancer J; 2012; 18(6):602-8. PubMed ID: 23187848 [TBL] [Abstract][Full Text] [Related]
4. New developments in the management of borderline resectable pancreatic cancers. Goodman MD; McPartland S; Huber K; Saif MW JOP; 2013 Jul; 14(4):334-6. PubMed ID: 23846921 [TBL] [Abstract][Full Text] [Related]
11. [Developments and controversies in neoadjuvant therapy for resectable pancreatic cancer]. Bai XL; Li X; Liang TB Zhonghua Wai Ke Za Zhi; 2020 Jul; 58(7):486-489. PubMed ID: 32610415 [TBL] [Abstract][Full Text] [Related]
12. Perioperative Therapy for Borderline Resectable Pancreatic Cancer: What and When? Kim MP; Katz MHG Ann Surg Oncol; 2019 Jun; 26(6):1596-1597. PubMed ID: 30680479 [No Abstract] [Full Text] [Related]
13. Neoadjuvant chemotherapy for localized pancreatic cancer: too little or too long? White RR; Evans DB Ann Surg Oncol; 2014 May; 21(5):1508-9. PubMed ID: 24452411 [No Abstract] [Full Text] [Related]
14. Status of neoadjuvant therapy for resectable pancreatic cancer. Hoffman JP Surg Oncol Clin N Am; 2010 Apr; 19(2):411-8. PubMed ID: 20159522 [TBL] [Abstract][Full Text] [Related]
15. Neoadjuvant Radiation Therapy Should Still Be Considered in Select Patients With Borderline Resectable Pancreas Cancer. Herman JM Int J Radiat Oncol Biol Phys; 2023 Jul; 116(4):709. PubMed ID: 37355307 [No Abstract] [Full Text] [Related]
16. [Future concepts for neoadjuvant and adjuvant treatment of (resectable) pancreatic cancer]. Seufferlein T; Michalski C Chirurg; 2022 May; 93(5):441-445. PubMed ID: 35376964 [TBL] [Abstract][Full Text] [Related]
17. Feasibility of preoperative combined radiation therapy and chemotherapy with 5-fluorouracil and cisplatin in potentially resectable pancreatic adenocarcinoma: The French SFRO-FFCD 97-04 Phase II trial. Mornex F; Girard N; Scoazec JY; Bossard N; Ychou M; Smith D; Seitz JF; Valette PJ; Roy P; Rouanet P; Ducreux M; Partensky C Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1471-8. PubMed ID: 16793214 [TBL] [Abstract][Full Text] [Related]
18. Neoadjuvant chemotherapy in resectable pancreatic cancer. Irmscher S; Senninger N; Schleicher C Ann Surg Oncol; 2008 Jul; 15(7):2059-60; author reply 2061. PubMed ID: 18266042 [No Abstract] [Full Text] [Related]
19. Neoadjuvant mFOLFIRINOX vs mFOLFIRINOX Plus Radiotherapy in Patients With Borderline Resectable Pancreatic Cancer-The A021501 Trial. Hintz B; Lee VJ JAMA Oncol; 2023 Feb; 9(2):277. PubMed ID: 36454584 [No Abstract] [Full Text] [Related]
20. Neoadjuvant mFOLFIRINOX vs mFOLFIRINOX Plus Radiotherapy in Patients With Borderline Resectable Pancreatic Cancer-The A021501 Trial. Grossberg AJ; Jethwa KR; Ellsworth SG JAMA Oncol; 2023 Feb; 9(2):275. PubMed ID: 36454560 [No Abstract] [Full Text] [Related] [Next] [New Search]